Mary Caffrey

The pay-for-performance deal comes as Januvia faces increased competition from newer drug classes, especially SGLT2 inhibitors and GLP-1 receptor agonists.

A study from Tufts University School of Medicine found that at age 10, obesity rates among children on the autism spectrum are not that much higher than children outside the spectrum, but rates diverge sharply as children get older.

The study found that in diabetic mice, a common sweetener appears to travel straight to the liver, where it causes fat to accumulate.

Coupons seem like a good deal for consumers, but they mask the true costs of drugs and force up premiums for everyone.

The findings are consistent with earlier work that show how soda companies spend heavily to promote their brands and thwart efforts to regulate or tax their products to address diabetes or obesity.

A letter from CMS Acting Administrator Andy Slavitt that was made public said that Mylan had been warned repeatedly that it was not using the right classification for the EpiPen, at taxpayers' expense.

States that have not expanded Medicaid are finding that rural hospitals struggle because they must still treat uninsured patients who show up for care, but they get less help from the federal government than in the past.

It is well known that the current A1C test could be more accurate. A group of researchers at Harvard believes they have found a way to personalize the test.

The study finds a molecular pathway to explain patterns long observed by those who work with patients being treated for both alcohol abuse and depression.

The former president said that Obama's signature law works well for those who are enrolled in Medicaid or who qualify for subsidies, but others have seen premium increases with lower benefits. The White House noted that Hillary Clinton supports improvements to the law.

Despite a name derived from the Greek terms for "self-eating," autophagy is not harmful; rather, it is essential for insulin secretion.

The Jackson Heart Study continues to yield insights about the nature of cardiovascular disease in minority populations.

According to the CDC, the majority of deaths from the flu occur in people over age 65.

In the year since New Jersey regulators approved OMNIA, the state's health insurance market has experienced the same upheaval seen elsewhere: the number of options on the exchanges has shrunk from 5 to 2.

The Abbott system allows physicians to gather up to 14 days' worth of glucose data without the patient having to interact with any device, or even calibrate it.

Data show that the biggest factor affecting distribution of uninsured rates was whether a state expanded Medicaid. Even with that limitation, uninsured rates have reached historic lows. The trouble is, only about one-fourth of Americans know this, and more have moved on to issues that affect them personally, such as the cost of premiums or high deductibles.

The company's announcement notably does not use the term "artificial pancreas," although the technology is a considerably more significant advance from the 530G threshold suspend device of 2013. When the description "artificial pancreas" was attached to that product, the term was met with howls of protest from the type 1 diabetes community.

Horizon Blue Cross Blue Shield's annual Patient-Centered Summit covered efforts by the state to expand naloxone access, provide peer support for those rescued from an opioid overdose, and the insurer's prevention practices.

The effort to reach young adults will allow them to shop for coverage entirely on mobile digital technology. But an economist interviewed earlier this month says it might not be enough.

The new guideline comes as FDA weighs an advisory panel recommendation for CGM dosing, which many see as a first step toward Medicare coverage.

Reports from the RAND Corporation, paid for by The Commonwealth Fund, portray starkly different results from the healthcare plans offered by the candidates for president.

Second of 2 parts: Coverage of the first half of the session appeared in the May issue of Evidence-Based Diabetes Management.1

Fitbits and other trackers are everywhere, but the study by JAMA finds that they may not help users with sustained weight loss, which has long eluded researchers.

A report finds that access to buprenorphine in Medicaid varies widely depending on where patients live. It's the latest example of the lack of mental health parity that former Congressman Patrick J. Kennedy confronts in his long quest for equity in care.

While declining smoking rates have caused cardiovascular disease to decline overall, some risk factors are rising, such as hypertension, diabetes, and obesity.

The study in BMJ found that people with the FTO gene were just as likely to lose weight through interventions, such as diet, exercise, or therapy.

While obesity is a known risk factor in gestational diabetes, women who were obese and also were depressed when they became pregnant were at greater risk of gestational diabetes than those who did not have depression.

The dispute between the ACLU and Colorado Medicaid has been seen in other states and with other payers. Policy questions on treatment for hepatitis C virus were examined in a special issue of The American Journal of Managed Care.

The Bloomberg American Health Initiative would cover research on obesity, gun violence, environmental threats, adolescent health, and drug addiction.

Evidence has been accumulating that links irregular sleep with chronic disease, but today is the first time the American Heart Association has issued a statement on the topic.